Skip to main content
Premium Trial:

Request an Annual Quote

NIAID to Devote Another $125M to Biocontainment Labs

NEW YORK, May 21 (GenomeWeb News) - The National Institute of Allergy and Infectious Diseases announced on Monday that it plans to provide $125 million in funding in FY 2005 for the construction of five to eight Regional Biocontainment Laboratories.


Winning institutions must provide matching funds of at least 25 percent of the total cost of the project. The NIAID will provide at least $15-$25 million in costs.


The NationalCenter for Research Resources will also provide an unspecified sum of money for research facilities improvements and upgrades, in collaboration with the NIAID project.


The RBLs will support NIAID funded research in biodefense and emerging infectious diseases and will be made available to assist in the case of a national emergency. They will supplement two national biocontainment laboratories and nine other RBLs funded last fall, as well as eight Regional Centers of Excellence in Biodefense and Emerging Infectious diseases. The RCEs will all fund research projects in genomics or proteomics as part of their mandates.


The NIAID is not yet soliciting applications for the project. The document announcing the intent to issue a request for applications can be found here.


The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.